No higher dose requirements with insulin detemir than glargine in type 2 diabetes: a crossover, double-blind, and randomized study using continuous glucose monitoring.

@article{King2010NoHD,
  title={No higher dose requirements with insulin detemir than glargine in type 2 diabetes: a crossover, double-blind, and randomized study using continuous glucose monitoring.},
  author={Allen King},
  journal={Journal of diabetes science and technology},
  year={2010},
  volume={4 1},
  pages={151-4}
}
  • Allen King
  • Published 2010 in Journal of diabetes science and technology
BACKGROUND In a previous publication we reported no difference in the 24-hour glucose response between two basal analog insulins, detemir and glargine, when taken once a day in type 2 diabetes mellitus (T2DM). We now report the dose comparison observed within this randomized, double-blind, crossover study. METHOD Of 36 patients on basal insulin and other noninsulin treatments, 29 completed the study. Both insulins were given once a day at 8 pm and no food was taken between 6 pm and the… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Insulin Detemir

Drugs • 2012
View 2 Excerpts

References

Publications referenced by this paper.
Showing 1-7 of 7 references

Similar Papers

Loading similar papers…